| Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma PK Haber, F Castet, M Torres-Martin, C Andreu-Oller, M Puigvehí, M Miho, ... Gastroenterology 164 (1), 72-88. e18, 2023 | 87 | 2023 |
| Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib Y Ha, MA Mohamed Ali, MM Petersen, WS Harmsen, TM Therneau, ... Hepatology international 14, 776-787, 2020 | 18 | 2020 |
| Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation MAM Ali, WS Harmsen, KH Morsy, GMK Galal, TM Therneau, LR Roberts BMC cancer 22 (1), 221, 2022 | 6 | 2022 |
| EVALUATION OF FACTORS ASSOCIATED WITH OUTCOMES OF HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH LIVER RESECTION: A REAL WORLD DATA ANALYSIS M Mohamed Ali, N Rodriguez-Payan, J Larson, J Yin, H Hassan, ... AASLD Liver Meeting 2021 76 (S1), 640A, 2021 | | 2021 |
| Mo1419 HEPATOCELLULAR CARCINOMA MORPHOLOGICAL AND CLINICAL CHARACTERISTICS AND PATIENT OUTCOME MAM Ali, F Hassan, WS Harmsen, T Therneau, LR Roberts Gastroenterology 158 (6), S-1403, 2020 | | 2020 |
| Determinants of Patients’ Outcomes Following Loco-regional ablation of Hepatocellular Carcinoma MAM Ali, MR Callstrom, LR Roberts Gastroenterology, S1239, 2018 | | 2018 |
Lewis RobertsProfessor of Medicine, Mayo Clinic在 mayo.edu 的电子邮件经过验证
